Select for export Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674241261779 PubMed 38907608 Copy citation Copy BibTeX Australian & New Zealand Journal of Psychiatry 2024-06-21 Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Oestreich OpenAlex Published psilocybin Chronic PainObservational StudySafety Observational Study More
Select for export Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241257839 PubMed 38888164 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-06-17 P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl OpenAlex Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1406888 PubMed 38919636 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-06-10 Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz OpenAlex Published psilocybin DepressionAddictionOCD Clinical Trial More
Select for export 5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2024-06-06 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin PTSDPersonality ChangeEmotional Processing Other More
Select for export Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action” Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1320780 PubMed 38983371 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-06-03 Julia Bornemann, James B. Close, Kirran Ahmad, Tommaso Barba, Kate Godfrey, Lauren Macdonald OpenAlex Published psilocybin Chronic PainNeuroplasticityBrain Imaging Randomized Controlled Trial More
Select for export Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2024.42.16_suppl.e22518 Copy citation Copy BibTeX Journal of Clinical Oncology 2024-05-31 Amrit Baral, Yue Pan, Alberto J. Caban Martinez, Paulo S. Pinheiro, WayWay M. Hlaing, Denise C. Vidot OpenAlex Published psilocybin Receptor PharmacologyObservational StudyAnimal Study Observational Study More
Select for export Is it now time to prepare psychiatry for a psychedelic future? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.2024.76 PubMed 38764044 Copy citation Copy BibTeX The British Journal of Psychiatry 2024-05-19 David Nutt, Ilana Crome, Allan H. Young OpenAlex Published psilocybin DepressionPTSDTreatment-Resistant Depression Other More
Select for export Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pcn5.196 Copy citation Copy BibTeX Psychiatry and Clinical Neurosciences Reports 2024-05-15 Shunichiro Ikeda, Toshihiko Kinoshita OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export What is needed for the roll-out of psychedelic treatments? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/yco.0000000000000946 PubMed 38726805 Copy citation Copy BibTeX Current Opinion in Psychiatry 2024-05-06 Stephen N. Xenakis, Scott Shannon OpenAlex Published psilocybin PTSDChronic PainPharmacology Clinical Trial More
Select for export 1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2024.02.179 Copy citation Copy BibTeX Biological Psychiatry 2024-04-28 Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, Jan Ramaekers OpenAlex Published psilocybin Emotional Processing Other More
Select for export Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-024-02575-9 PubMed 38678087 Copy citation Copy BibTeX Molecular Psychiatry 2024-04-26 Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus OpenAlex Published psilocybin DepressionEating DisordersPharmacology Clinical Trial More
Select for export The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12888-024-05768-2 PubMed 38658877 Copy citation Copy BibTeX BMC Psychiatry 2024-04-24 Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen OpenAlex Published psilocybin Chronic PainBrain ImagingMechanism of Action Clinical Trial More
Select for export The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-04-18 Section for Affective Disorders; Northern Stockholm Psychiatry ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1301960 PubMed 38699449 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-04-17 Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola OpenAlex Published psilocybin AnxietyEnd-of-Life DistressChronic Pain Observational Study More
Select for export Psychedelics and the ‘inner healer’: Myth or mechanism? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241239206 PubMed 38605658 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-04-11 Joseph Peill, M. Marguilho, David Erritzøe, Tommaso Barba, Kyle T. Greenway, Fernando E. Rosas OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Randomized Controlled Trial More
Select for export Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2024.0420 PubMed 38598200 Copy citation Copy BibTeX JAMA Psychiatry 2024-04-09 Eiko I. Fried, Ioana A. Cristea, Florian Naudet OpenAlex Published psilocybin DepressionSafety Other More
Select for export Mechanisms of therapeutic change after psychedelic treatment in OCD No abstract availability was recorded for this entry. Details DOI 10.1016/j.psychres.2024.115907 PubMed 38615521 Copy citation Copy BibTeX Psychiatry Research 2024-04-06 Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi OpenAlex Published psilocybin OCDMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/15563650.2024.2346612 PubMed 38753585 Copy citation Copy BibTeX Clinical Toxicology 2024-04-01 Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett OpenAlex Published psilocybin Clinical TrialObservational StudyHealthcare Workers Clinical Trial More
Select for export Current situation regarding psychedelics and magic mushroom in Korea Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.1695 Copy citation Copy BibTeX European Psychiatry 2024-03-31 J. S. Seo OpenAlex Published psilocybinpsilocin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
